Metabolism2012ObservationalMetabolic/Reproductive

Application of bioregulating therapy in complex treatment of temporomandibular joint diseases in people of elderly and senile age

Iordanishvili A.K., Samsonov V.V., Soldatova L.N., Polens A.A., Ryzhak G.A.

Not stated in the PubMed record

Advances in Gerontology (Uspekhi Gerontologii) 25(1): 181-186

Study Type
Observational

Abstract

Article in Russian. Observational report on 62 older patients with temporomandibular joint problems treated with a care package (dental prosthetics, functional therapy, medication) that included the cartilage and bone peptide complex Sigumir. The authors report reduced pain, better mouth opening and chewing, and shorter treatment. Sigumir was one part of combined care, so its own effect cannot be separated. Summary based on the PubMed abstract (PMID 22708467).

What the study did

Article in Russian. Observational report on 62 older patients with temporomandibular joint problems treated with a care package (dental prosthetics, functional therapy, medication) that included the cartilage and bone peptide complex Sigumir. The authors report reduced pain, better mouth opening and chewing, and shorter treatment. Sigumir was one part of combined care, so its own effect cannot be separated.

Reading it honestly

This summary is based on the PubMed abstract (PMID 22708467). It describes research on the named preparation, not on any capsule product sold today, and it is not a claim that any product treats or prevents a disease.


Next stepOral bioregulator · Vita-Stream

Where to get Sigumir

Sigumir (A-4), the cartilage bioregulator this study used, is sold by Vita-Stream, our affiliate partner. Vita's own US-made cartilage product, Cartesyl, is a different formulation that was not studied here.

Use code KymataLabs at checkout

Affiliate links: The Bioregulator Atlas earns a commission if you buy through these Vita-Stream links, at no extra cost to you. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare professional before use.

Study Limitations

  • •Summary based on the PubMed abstract only
  • •Single research group; independent replication is limited
  • •Results concern the studied preparation, not any capsule product

Key Findings

  • ✓Observational report
  • ✓Combined-care design
  • ✓Russian-language publication

Mechanism of Action

Not studied.